Compile Data Set for Download or QSAR
maximum 50k data
Found 51 Enz. Inhib. hit(s) with all data for entry = 49
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106317(US9695175, 22)
Affinity DataIC50:  21nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107092(US9695175, 43)
Affinity DataIC50:  23nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106309(US9695175, 19)
Affinity DataIC50:  26nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106379(US9695175, 28)
Affinity DataIC50:  28nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106383(US9695175, 29)
Affinity DataIC50:  30nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107096(US9695175, 44)
Affinity DataIC50:  32nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106237(US9695175, 6)
Affinity DataIC50:  37nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107317(US9695175, 47)
Affinity DataIC50:  38nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107371(US9695175, 49)
Affinity DataIC50:  38nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106336(US9695175, 23)
Affinity DataIC50:  42nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106339(US9695175, 24)
Affinity DataIC50:  43nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106231(US9695175, 5)
Affinity DataIC50:  45nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106190(US9695175, 1)
Affinity DataIC50:  49nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106630(US9695175, 37)
Affinity DataIC50:  51nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106386(US9695175, 30)
Affinity DataIC50:  52nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106392(US9695175, 34)
Affinity DataIC50:  53nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106571(US9695175, 35)
Affinity DataIC50:  65nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106227(US9695175, 3)
Affinity DataIC50:  69nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106239(US9695175, 7)
Affinity DataIC50:  76nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106301(US9695175, 17)
Affinity DataIC50:  78nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107053(US9695175, 39)
Affinity DataIC50:  80nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106387(US9695175, 31)
Affinity DataIC50:  81nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106730(US9695175, 38)
Affinity DataIC50:  83nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106230(US9695175, 4)
Affinity DataIC50:  84nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106308(US9695175, 18)
Affinity DataIC50:  91nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106274(US9695175, 14)
Affinity DataIC50:  102nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106388(US9695175, 32)
Affinity DataIC50:  109nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106581(US9695175, 36)
Affinity DataIC50:  113nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106241(US9695175, 9)
Affinity DataIC50:  119nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106354(US9695175, 25)
Affinity DataIC50:  125nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107090(US9695175, 41)
Affinity DataIC50:  127nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107091(US9695175, 42)
Affinity DataIC50:  136nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106313(US9695175, 20)
Affinity DataIC50:  137nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106363(US9695175, 27)
Affinity DataIC50:  148nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106222(US9695175, 2)
Affinity DataIC50:  148nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106240(US9695175, 8)
Affinity DataIC50:  149nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106266(US9695175, 12)
Affinity DataIC50:  158nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107199(US9695175, 46)
Affinity DataIC50:  159nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106315(US9695175, 21)
Affinity DataIC50:  180nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106273(US9695175, 13)
Affinity DataIC50:  182nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106264(US9695175, 11)
Affinity DataIC50:  194nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107088(US9695175, 40)
Affinity DataIC50:  203nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106389(US9695175, 33)
Affinity DataIC50:  242nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106294(US9695175, 16)
Affinity DataIC50:  247nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106247(US9695175, 10)
Affinity DataIC50:  261nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107113(US9695175, 45)
Affinity DataIC50:  274nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106360(US9695175, 26)
Affinity DataIC50:  357nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM106277(US9695175, 15)
Affinity DataIC50:  380nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107634(US9695175, 52)
Affinity DataIC50:  568nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHepatocyte growth factor receptor [1038-1346](Homo sapiens (Human))
Cb Therapeutics

US Patent
LigandPNGBDBM107497(US9695175, 50)
Affinity DataIC50:  1.44E+3nMT: 2°CAssay Description:Optiplate-384 well plate (PerKinElmer), kinase buffer (50 mM Hepes pH7.5, 25 mM NaCl, 2 mM DTT, 0.01% Tween 20, 5 mM Mg2+, 0.5 mM Mn2+), c-Met kinase...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: